Objective: To investigate the relationship of verumontanum hypertrophy with chronic prostatitis.
Methods: Fifty-two patients with chronic prostatitis underwent cystourethroscopy for comparing the size of the verumontanum before and after treatment.
Results: Before treatment, all the patients showed different degrees verumontanum hypertrophy, of whom 50 were treated by conventional drug therapy, and the other 2 with voiding dysfunction by drug therapy combined with transurethral resection. Cystourethroscopy revealed significantly decreased size of the verumontanum in 44 of the patients after treatment (P < 0.05).
Conclusion: Patients with chronic prostatitis often have verumontanum hypertrophy, which could be an indicator of the effect of treatment.